T-cells -- a type of white blood cell that learns to recognize and attack microbial pathogens -- are activated by a pain receptor, scientists have discovered. The study shows that the receptor helps regulate intestinal inflammation in mice and that its activity can be manipulated, offering a potential new target for treating certain autoimmune disorders, such as Crohn's disease and possibly multiple sclerosis.
T-cells -- a type of white blood cell that learns to recognize and attack microbial pathogens -- are activated by a pain receptor, scientists have discovered. The study shows that the receptor helps regulate intestinal inflammation in mice and that its activity can be manipulated, offering a potential new target for treating certain autoimmune disorders, such as Crohn's disease and possibly multiple sclerosis.
Share this Article
Recommended